Utilizing granzyme B, researchers have uncovered a novel method for detecting tumors response to immunotherapy therapy earlier.
Browsing: immune response
A recent study has demonstrated that patients with elevated levels of tumor-associated immune cells and CD8 T-cells as well as lower levels of regulatory T-cells exhibit more favorable responses to immunotherapy.
Researchers have identified a mutation that enables melanoma cells to remain undetected by the immune system.
Researchers have discovered a new immunosuppressive activity of myeloid-derived suppressor cells that may provide insight for the design of more effective cancer immunotherapies.
A calcium ion channel present in T cells has been identified by researchers as a potential target to reduce growth in head and neck cancer.
Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy
The authors review the current understanding of cancer immunology including immune surveillance and immune editing in the context of prominent innate suppressor cells, and their targetability by nanoparticular immunotherapy with small molecules or siRNA.
The authors discuss the potential application of mesenchymal stromal cells within cancer immunotherapy.
Over the coming weeks, we will be carrying out a Spotlight exploring the intricacies of the interactions of cancer and the immune system on Oncology Central, highlighting key journal content discussing the topic and featuring exclusive content from experts in the field. Click on this post to find out more.
A new review highlights the combination of radiation therapy with immunotherapy and the possible resultant synergistic effects when used to treat melanoma.
A group of eight immune genes have been identified that could help to predict glioblastoma survival.